Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

Clinical trial NCT00589563 · COMPLETED

Trial details

NCT number: NCT00589563
Sponsor: City of Hope Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Graft Versus Host Disease Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Secondary Myelofibrosis Small Intestine Cancer

Start date: 2007-05-01
Primary completion: 2012-02-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.